U099--Test2Learn Education (PGx) (VA-26-00020748)

Form / Attachment / Pricing Sheet

This document is a fillable price-cost schedule for the "Pharmacogenomics Education and Training" opportunity. It outlines the specific line items for which bidders are expected to provide pricing.

• Base Period (16 March 2026 – 15 March 2027): Includes line items for Program Management (Kickoff Meeting, Project Management Plan, Reporting, Data Use Agreement), End User Support (Contractor - Hosted Website, Student Participant Course Access, Course Development & Delivery), and Strategic Communication (Communication Plan).
• Option Year 1 (16 March 2027 – 15 March 2028): Mirrors the base period's line items.
• Option Year 2 (16 March 2028 – 15 March 2029): Mirrors the base period's line items.
• For each line item, bidders must provide Quantity, Unit, Unit Price, and Amount.
• "NSP" indicates "Non-Stocked Product" or similar, suggesting a fixed price or not applicable for unit pricing.

This schedule is critical for bidders to understand the cost structure of the requirement and to prepare their pricing proposals. Bidders must accurately fill in the unit prices and calculate the total amounts for each line item and contract period to submit a compliant bid.

Solicitation / RFP / RFQ

This solicitation, "ATTACHMENT A - 36C10X26Q0050-RFQ.pdf", is a Request for Quotation (RFQ) for "Pharmacogenomics Education and Training" services for the Department of Veterans Affairs. The goal is to provide continuing education and accredited training to VA clinicians to enhance their ability to translate pharmacogenomics (PGx) test results into effective patient care plans, improve medication efficacy and safety, and efficiently apply PGx into patient care.

• Develop and deliver accredited multimodal PGx education and training to VA clinicians.

• Training should support the translation of PGx testing into personalized patient care plans, resulting in certification and continuing education.

• Offer multimodal education (asynchronous and synchronous) for clinicians with varying expertise.

• Evaluate competency in clinical application of PGx.

• Empower clinicians to incorporate PGx into medication management services.

• Provide continuing education credit from accrediting bodies (ACPE, ACCME, ANCC, AAPA).

• Develop a data use agreement for educational analyses.

• Provide a contractor-hosted website for course registration and materials.

• Offer online student participant access for at least 1,000 participants per contract period.

• Develop and deliver both on-demand, self-directed asynchronous curriculum and synchronous, live curriculum.

• Curricula to leverage multiple media formats, include case-based discussions, and a final exam.

• Offer specialty on-demand CE courses (e.g., Cardiology, Oncology, Mental Health, Pain).

• Develop a communication plan for marketing the training program.

• Contract Type: Firm Fixed Price.

• Period of Performance: Base Period (12 months from award), Option Period 1 (12 months), Option Period 2 (12 months).

• Place of Performance: Contractor's facility.

• Questions Due: 02-19-2026, 2:00 PM EST.

• Quote Due: 02-26-2026, 12:00 PM EST.

• Proposals will be evaluated using a best-value trade-off process, considering Technical Capability, Past Performance, and Price. Technical Capability and Past Performance are significantly more important than Price.

• Proposal submission requirements include specific formatting, page limitations, and content for four volumes: Technical Capability, Past Performance, Price, and SF1449/Amendments/Other Documents.

• NAICS Code: 611430 (Professional and managerial development training).

• Size Standard: $15 Million.

• This acquisition is UNRESTRICTED or SET ASIDE: Small Business (checkbox is not marked, implying unrestricted, but NAICS code and size standard are provided).

• The document includes numerous FAR and VAAR clauses and provisions related to contract terms, conditions, representations, and certifications.

Questions & Answers / Clarifications

This document provides responses to vendor questions regarding the solicitation.

• Incumbent Contractor: The incumbent contractor is the University of Pittsburg.
• Due Date Extensions: The Government will not automatically extend due dates. Extensions will only be considered for reasonable requests that include specific circumstances.
• Posting of Answers: Answers to questions are planned to be posted within 2 business days of the Q&A close date.

This Q&A document clarifies aspects of the solicitation, including incumbent information and the process for requesting due date extensions. Bidders should note the timeline for receiving answers to their questions.

Solicitation / RFP / RFQ

This is a combined synopsis/solicitation (RFQ) for Pharmacogenomics (PGx) Education and Training for the Department of Veterans Affairs (VA) National Pharmacogenomics Program. The goal is to provide accredited, multimodal education and training to VA clinicians to enable them to translate PGx testing into personalized patient care plans, leading to certification and continuing education.

• Provide accredited multimodal education and training to VA clinicians.

• Training should vary by clinician role, experience, and engagement with PGx.

• Deliver asynchronous and synchronous comprehensive PGx training.

• Evaluate clinician competency in clinical application of PGx.

• Empower clinicians to incorporate PGx into medication management services.

• Increase the number of VA clinicians who can translate PGx profiles to treatment plans.

• Offer continuing education credits from ACPE, ACCME, ANCC, and AAPA.

• Develop a data use agreement for educational analyses.

• All work must be in accordance with the attached Performance Work Statement (PWS).

• Award will be a single contract.

• Period of Performance: Begins March 16, 2026, with two twelve-month option periods.

• Offerors are requested to quote Firm Fixed Prices.

• Award will be issued on a Standard Form 1449.

• Solicitation Number: 36C10X26Q0050

• Response Date/Time: February 26, 2026, 12:00 PM Eastern Time, New York, USA.

• Due date for questions: Thursday, February 19, 2026, 14:00 EST.

• Questions must be submitted in writing via email to Wanda.Edwards@va.gov.

• This solicitation is Unrestricted.

• Offerors MUST be registered in the System for Award Management (SAM) database to receive an award.

• Incorporates VA Class Deviations implementing the Revolutionary FAR Overhaul (RFO).

• Provisions and clauses are effective through Federal Acquisition Circular (FAC) 2025-04 and VAAR.

• Referenced attachments include: PWS (Attachment A), Price/Cost Schedule (Attachment B), and Solicitation Questions and Answers (Attachment C).